The authors of An additional paper reported the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [eleven].Integrated knowledge logging modules history regulated and measured data and supply useable final results information. As with al